AMBUJACEM
21.02.2022 - Jefferies on AMBUJACEM Maintain Buy CMP 338 Target 425
21.02.2022 - CLSA on AMBUJACEM Maintain Outperform CMP 338 Target 390
21.02.2022 - CITI on AMBUJACEM Maintain Downgrade Neutral CMP 338 Target 365
18.02.2022 - UBS on AMBUJACEM Maintain Neutral CMP 338.35 Target 420
